Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02830 |
| Species: | Homo sapiens |
| Position : | chr20:48915257-48915803 |
| Year: | 2024 |
| Title: | Enhancer-promoter hubs organize transcriptional networks promoting oncogenesis and drug resistance. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | breast cancer |
| PMID: | 39277592 |
| MONDO: | MONDO:0007254 |
| Tissue: | breast |
| Tissue Ontology ID: | UBERON:0000310 |
| Cell Source: | MDA-MB-157 |
| CVCL ID: | CVCL_0618 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Chromatin interaction assay; Epigenomic enhancer profiling; Cross-database enhancer annotation |
| High Throughput Method: | SMC1 HiChIP; H3K27ac ChIP-seq; RNA-seq |
| Low Throughput Method: | 3C |
| Target gene : | CEBPB |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|